SB

Samsara BioCapital Portfolio holdings

AUM $489M
This Quarter Return
-22.13%
1 Year Return
+135.25%
3 Year Return
+909.96%
5 Year Return
+774.56%
10 Year Return
AUM
$395M
AUM Growth
+$395M
Cap. Flow
+$43.8M
Cap. Flow %
11.07%
Top 10 Hldgs %
64.49%
Holding
56
New
7
Increased
4
Reduced
3
Closed
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
KDNY
1
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$75.1M 18.91% 4,591,888
LENZ
2
LENZ Therapeutics
LENZ
$1.1B
$41.2M 10.36% 8,072,603 +220,670 +3% +$1.13M
NKTX icon
3
Nkarta
NKTX
$151M
$23.2M 5.83% 2,034,702 -1 -0% -$11
TIL icon
4
Instil Bio
TIL
$182M
$21.4M 5.39% 1,991,950
ISEE
5
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$21.2M 5.35% 1,262,551
CNTA
6
Centessa Pharmaceuticals
CNTA
$2.25B
$16.9M 4.25% 1,884,096 +424,403 +29% +$3.81M
FMTX
7
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
$14.6M 3.67% 1,565,526
ACLX icon
8
Arcellx
ACLX
$3.85B
$14M 3.53% +999,727 New +$14M
STRO icon
9
Sutro Biopharma
STRO
$72.7M
$13.8M 3.47% 1,675,579
ACRS icon
10
Aclaris Therapeutics
ACRS
$209M
$13.7M 3.45% 794,171
ICPT
11
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$10.4M 2.62% 640,688
RAIN
12
DELISTED
Rain Oncology Inc. Common Stock
RAIN
$7.97M 2.01% 1,571,379
ZYME icon
13
Zymeworks
ZYME
$1.12B
$6.36M 1.6% +970,987 New +$6.36M
IOBT icon
14
IO Biotech
IOBT
$104M
$5.94M 1.49% 1,120,437
JANX icon
15
Janux Therapeutics
JANX
$1.37B
$5.91M 1.49% 411,871
EYPT icon
16
EyePoint Pharmaceuticals
EYPT
$797M
$5.83M 1.47% 480,000
VRNA
17
Verona Pharma
VRNA
$9.16B
$5.54M 1.4% 1,111,112
JYAC
18
DELISTED
Jiya Acquisition Corp. Class A Common Stock
JYAC
$4.98M 1.25% 507,041
SNCE
19
DELISTED
Science 37 Holdings, Inc. Common Stock
SNCE
$4.82M 1.21% 900,000
IMCR icon
20
Immunocore
IMCR
$1.62B
$4.81M 1.21% 160,963 +96,963 +152% +$2.9M
TNGX icon
21
Tango Therapeutics
TNGX
$747M
$4.78M 1.2% 630,000
AVDL
22
Avadel Pharmaceuticals
AVDL
$1.43B
$4.5M 1.13% 659,409
ALXO icon
23
ALX Oncology
ALXO
$62.7M
$4.44M 1.12% +262,786 New +$4.44M
SRRK icon
24
Scholar Rock
SRRK
$3.14B
$4.38M 1.1% +339,611 New +$4.38M
DICE
25
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
$4.37M 1.1% +228,466 New +$4.37M